{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T12:31:54Z","timestamp":1790339514974,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000943","name":"Commonwealth Scientific Industrial Research Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000943","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001798","name":"Edith Cowan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001798","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Mental Health Research Institute"},{"name":"National Ageing Research Institute"},{"name":"Austin Health"},{"name":"CogState Ltd"},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008716","name":"Science and Industry Endowment Fund","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008716","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Cooperative Research Centre for Mental Health"}],"content-domain":{"domain":["clinicalkey.com","neurobiologyofaging.org","clinicalkey.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.neurobiolaging.2014.12.015","type":"journal-article","created":{"date-parts":[[2014,12,20]],"date-time":"2014-12-20T11:06:10Z","timestamp":1419073570000},"page":"1231-1238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"title":["Trajectories of memory decline in preclinical Alzheimer's disease: results from the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing"],"prefix":"10.1016","volume":"36","author":[{"given":"Robert H.","family":"Pietrzak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen Ying","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ames","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karra","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Restrepo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph N.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Rembach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon M.","family":"Laws","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin L.","family":"Masters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor L.","family":"Villemagne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C.","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Maruff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2014.12.015_bib1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1056\/NEJMoa0809437","article-title":"Longitudinal modeling of age-related memory decline and the APOE \u03b54 effect","volume":"361","author":"Caselli","year":"2009","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neurobiolaging.2014.12.015_bib2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jama.2010.2008","article-title":"Use of florbetapir-PET for imaging beta-amyloid pathology","volume":"305","author":"Clark","year":"2011","journal-title":"J.\u00a0Am. Med. Assoc."},{"key":"10.1016\/j.neurobiolaging.2014.12.015_bib3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1017\/S1041610292000991","article-title":"Assessment of memory complaint in age-associated memory impairment: the MAC-Q","volume":"4","author":"Crook","year":"1992","journal-title":"Int. Psychogeriatr."},{"key":"10.1016\/j.neurobiolaging.2014.12.015_bib4","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3233\/JAD-2011-110818","article-title":"Episodic memory decline predicts cortical amyloid status in community-dwelling older adults","volume":"27","author":"Darby","year":"2011","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2014.12.015_bib5","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1001\/archneurol.2011.3354","article-title":"Amyloid-b-associated clinical decline occurs only in the presence of elevated p-tau","volume":"69","author":"Desikan","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.12.015_bib6","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/mp.2014.9","article-title":"Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter study","volume":"19","author":"Doraiswamy","year":"2014","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2014.12.015_bib7","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/arclin\/act047","article-title":"Amyloid deposition and cognition in older adults: the effects of premorbid intellect","volume":"28","author":"Duff","year":"2013","journal-title":"Arch. Clin. Neuropsychol."},{"key":"10.1016\/j.neurobiolaging.2014.12.015_bib8","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1017\/S1041610209009405","article-title":"The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease","volume":"21","author":"Ellis","year":"2009","journal-title":"Int. Psychogeriatrics"},{"key":"10.1016\/j.neurobiolaging.2014.12.015_bib9","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1017\/S1041610213001087","article-title":"The association of Abeta amyloid and composite cognitive measures in healthy older adults and MCI","volume":"25","author":"Harrington","year":"2013","journal-title":"Int. Psychogeriatr."},{"key":"10.1016\/j.neurobiolaging.2014.12.015_bib10","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/ageing\/afr101","article-title":"Cognitive decline in the elderly: an analysis of population heterogeneity","volume":"40","author":"Hayden","year":"2011","journal-title":"Age and Ageing"},{"key":"10.1016\/j.neurobiolaging.2014.12.015_bib11","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1001\/archneurol.2009.237","article-title":"Effects of family history and APOE e4 status on cognitive decline in the absence of AD: the Cache County Study","volume":"66","author":"Hayden","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.12.015_bib12","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1001\/archgenpsychiatry.2010.30","article-title":"Prediction of dementia by subjective memory impairment: effects of severity and temporal association with cognitive impairment","volume":"67","author":"Jessen","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2014.12.015_bib13","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jalz.2012.09.017","article-title":"AD dementia risk in late MCI, in early MCI, and in subjective memory impairment","volume":"10","author":"Jessen","year":"2014","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2014.12.015_bib14","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/ana.23816","article-title":"Brain injury biomarkers are not dependent on \u03b2-amyloid in normal elderly","volume":"73","author":"Knopman","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.12.015_bib15","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1037\/a0032321","article-title":"Cognitive consequences of high Abeta amyloid in mild cognitive impairment and healthy older adults: implications for early detection of Alzheimer's disease","volume":"27","author":"Lim","year":"2013","journal-title":"Neuropsychology"},{"key":"10.1016\/j.neurobiolaging.2014.12.015_bib16","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1212\/WNL.0b013e31826e9ae6","article-title":"Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults","volume":"79","author":"Lim","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2014.12.015_bib17","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/brain\/awt286","article-title":"Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease","volume":"137","author":"Lim","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2014.12.015_bib18","doi-asserted-by":"crossref","first-page":"675","DOI":"10.3233\/JAD-2012-121516","article-title":"Rapid decline in episodic memory in healthy older adults with high amyloid-beta","volume":"33","author":"Lim","year":"2013","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2014.12.015_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/mp.2014.123","article-title":"APOE and BDNF polymorphisms moderate amyloid \u03b2-related cognitive decline in preclinical Alzheimer's disease","author":"Lim","year":"2014","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2014.12.015_bib20","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1212\/WNL.0000000000000431","article-title":"Amyloid and APOE E4 interact to influence short-term decline in preclinical Alzheimer's disease","volume":"82","author":"Mormino","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2014.12.015_bib21","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ana.21843","article-title":"APOE predicts Ab but not tau Alzheimer's pathology in cognitively normal aging","volume":"67","author":"Morris","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.12.015_bib22","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1001\/jamaneurol.2014.1491","article-title":"Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study","volume":"71","author":"Naj","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.12.015_bib23","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1037\/a0031063","article-title":"Subgroup of ADNI normal controls characterized by atrophy and cognitive decline associated with vascular damage","volume":"28","author":"Nettiksimmons","year":"2013","journal-title":"Psychol. Aging"},{"key":"10.1016\/j.neurobiolaging.2014.12.015_bib24","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1080\/10705510701575396","article-title":"Deciding on the number of classes in latent class analysis and growth mixture modeling. A Monte Carlo simulation study","volume":"14","author":"Nylund","year":"2007","journal-title":"Struct. Equation Model."},{"key":"10.1016\/j.neurobiolaging.2014.12.015_bib25","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1192\/bjp.bp.113.134239","article-title":"Anxiety symptoms, cerebral amyloid burden and memory decline in healthy older adults without dementia: 3-year prospective cohort study","volume":"204","author":"Pietrzak","year":"2014","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2014.12.015_bib26","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/ana.24040","article-title":"Predicting Alzheimer disease with \u03b2-amyloid imaging: results from the Australian Imaging, Biomarkers, and Lifestyle Study of Ageing","volume":"74","author":"Rowe","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.12.015_bib27","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.neurobiolaging.2010.04.007","article-title":"Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) Study of Aging","volume":"31","author":"Rowe","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2014.12.015_bib28","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ana.22068","article-title":"18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial","volume":"68","author":"Vandenberghe","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.12.015_bib29","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","article-title":"Amyloid \u03b2 deposition, neurodegeneration and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study","volume":"12","author":"Villemagne","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.12.015_bib30","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1212\/WNL.0b013e318245f447","article-title":"Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease","volume":"78","author":"Wagner","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2014.12.015_bib31","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1212\/WNL.0b013e3181f39adc","article-title":"Neurodegenerative basis of age-related cognitive decline","volume":"75","author":"Wilson","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2014.12.015_bib32","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1212\/WNL.0000000000000285","article-title":"Incidence of cerebral microbleeds in preclinical Alzheimer disease","volume":"82","author":"Yates","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2014.12.015_bib33","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatrica Scand."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458014008318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458014008318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,18]],"date-time":"2019-08-18T17:08:51Z","timestamp":1566148131000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458014008318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0197458014008318"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.12.015","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trajectories of memory decline in preclinical Alzheimer's disease: results from the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.12.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}